GFAP and COVID-19: Studies, including our own, have observed neuroinflammation and apoptosis in reactive astrocytes, indicated by increased glial fibrillary acidic protein (GFAP), an astrocyte-specific brain injury marker [43,44], in postmortem brain tissues from COVID-19 individuals (Figure 1B-c).